APA (7th ed.) Citation

Datoo, M. S., Dicko, A., Tinto, H., Ouédraogo, J., Hamaluba, M., Olotu, A., . . . Chandramohan, D. (2024). Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: A multicentre, double-blind, randomised, phase 3 trial. Lancet, 403(10426), 533. https://doi.org/10.1016/S0140-6736(23)02511-4

Chicago Style (17th ed.) Citation

Datoo, Mehreen S., et al. "Safety and Efficacy of Malaria Vaccine Candidate R21/Matrix-M in African Children: A Multicentre, Double-blind, Randomised, Phase 3 Trial." Lancet 403, no. 10426 (2024): 533. https://doi.org/10.1016/S0140-6736(23)02511-4.

MLA (9th ed.) Citation

Datoo, Mehreen S., et al. "Safety and Efficacy of Malaria Vaccine Candidate R21/Matrix-M in African Children: A Multicentre, Double-blind, Randomised, Phase 3 Trial." Lancet, vol. 403, no. 10426, 2024, p. 533, https://doi.org/10.1016/S0140-6736(23)02511-4.